Compendium Listing Not A Shield Against Legal Action For Off-Label Uses
Executive Summary
The fact that a drug may be listed for an off-label indication in an approved compendium does not shield the manufacturer from legal action under provisions in the Food, Drug and Cosmetics Act or the False Claims Act, legal experts at a recent Food and Drug Law Institute conference warned